Bedel Financial Consulting’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-887
Closed -$113K 948
2022
Q1
$113K Sell
887
-20
-2% -$2.41K 0.04% 254
2021
Q4
$112K Sell
907
-7
-0.8% -$916 0.03% 262
2021
Q3
$130K Buy
914
+7
+0.8% +$1.03K 0.04% 232
2021
Q2
$142K Buy
907
+1
+0.1% +$162 0.05% 221
2021
Q1
$141K Hold
906
0.05% 214
2020
Q4
$136K Hold
906
0.06% 186
2020
Q3
$120K Buy
906
+1
+0.1% +$131 0.06% 185
2020
Q2
$105K Sell
905
-103
-10% -$11.9K 0.06% 193
2020
Q1
$99K Hold
1,008
0.07% 179
2019
Q4
$146K Sell
1,008
-38
-4% -$5.25K 0.08% 171
2019
Q3
$140K Hold
1,046
0.08% 172
2019
Q2
$120K Hold
1,046
0.07% 182
2019
Q1
$130K Buy
1,046
+1
+0.1% +$114 0.08% 169
2018
Q4
$105K Hold
1,045
0.08% 173
2018
Q3
$129K Buy
1,045
+1
+0.1% +$119 0.09% 173
2018
Q2
$113K Hold
1,044
0.08% 180
2018
Q1
$111K Buy
+1,044
New +$121K 0.08% 185

Other funds holding ZBH

Bedel Financial Consulting's ZBH Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 887 shares — an estimated $113K sold.

Bedel Financial Consulting first reported a position in ZBH in Q1 2018 and held it in 17 quarters. The position peaked at $146K in Q4 2019. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 887 Zimmer Biomet shares in Q2 2022, an estimated $113K.
  • Bedel Financial Consulting first reported a position in Zimmer Biomet in Q1 2018 and held it in 17 quarters.
  • Bedel Financial Consulting's Zimmer Biomet position peaked at $146K in Q4 2019.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.